Massad Islam M, Abu-Ali Hamdi M, Abu-Halaweh Sami A, Badran Izdiad Z
Department of General Surgery, Division of Anesthesia and Intensive Care, Jordan University Hospital, PO Box 13046, Amman 11942, Jordan.
Saudi Med J. 2006 Jul;27(7):997-1000.
Pain is a well-known complication of intravenous administration of propofol, and to find out the optimal method to decrease this pain, we studied 4 methods of delivering propofol.
The study took place at Jordan University Hospital, Amman, Jordan between November 2004 and March 2005 on 200 patients. The patients were divided into 4 groups, group I (n=50), the control group, propofol 1% was given alone. Group II (n=50), patients received propofol 1% premixed with 40 mg of lidocaine. Group III (n=50), patients received propofol 1% 60 seconds after giving 40 mg of lidocaine. Group IV (n=50), patients had venous occlusion for 60 seconds with the use of lidocaine 1% (40 mg), followed by release of the occlusion and administration of the propofol. Pain was assessed during injection and categorized into: no pain, pain, and pain with behavioral changes.
In group I (control), 35 patient complained of pain, compared to 26 in group II, 23 in group III, and 7 patients in group IV, with a significant reduction in the incidence and intensity of pain in group II, III, and IV compared with the control (p<0.005). The best reduction of intensity and incidence was achieved in group VI, when compared with groups I, II and III (p<0.005), with no statistical difference between group II and III when compared with each other.
Of the 4 methods studied, the optimal method to decrease the incidence and intensity of pain resulting from propofol injection is to inject lidocaine while applying venous occlusion for 60 seconds prior to administering propofol.
疼痛是丙泊酚静脉给药的一种常见并发症,为找出减轻这种疼痛的最佳方法,我们研究了4种丙泊酚给药方法。
该研究于2004年11月至2005年3月在约旦安曼的约旦大学医院对200例患者进行。患者被分为4组,第I组(n = 50)为对照组,单独给予1%丙泊酚。第II组(n = 50),患者接受与40 mg利多卡因预混的1%丙泊酚。第III组(n = 50),患者在给予40 mg利多卡因60秒后接受1%丙泊酚。第IV组(n = 50),患者使用1%利多卡因(40 mg)进行60秒的静脉闭塞,随后解除闭塞并给予丙泊酚。在注射过程中评估疼痛,并分为:无疼痛、疼痛和伴有行为改变的疼痛。
第I组(对照组)有35例患者主诉疼痛,第II组为26例,第III组为23例,第IV组为7例,与对照组相比,第II、III和IV组疼痛的发生率和强度显著降低(p < 0.005)。与第I、II和III组相比,第IV组在强度和发生率降低方面效果最佳(p < 0.005),第II组和第III组之间相互比较无统计学差异。
在所研究的4种方法中,降低丙泊酚注射所致疼痛发生率和强度的最佳方法是在给予丙泊酚前应用静脉闭塞60秒的同时注射利多卡因。